NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
28.57
Dollar change
+0.36
Percentage change
1.28
%
Index- P/E25.17 EPS (ttm)1.13 Insider Own0.07% Shs Outstand586.83M Perf Week5.27%
Market Cap16.77B Forward P/E11.72 EPS next Y2.44 Insider Trans0.00% Shs Float586.39M Perf Month-0.28%
Enterprise Value28.52B PEG1.38 EPS next Q0.49 Inst Own5.98% Short Float0.40% Perf Quarter15.29%
Income665.99M P/S0.80 EPS this Y30.43% Inst Trans3.37% Short Ratio4.88 Perf Half Y25.80%
Sales20.92B P/B1.08 EPS next Y14.53% ROA1.84% Short Interest2.33M Perf YTD26.19%
Book/sh26.46 P/C14.49 EPS next 5Y18.21% ROE4.36% 52W High30.46 -6.20% Perf Year49.58%
Cash/sh1.97 P/FCF9.10 EPS past 3/5Y-20.26% -14.87% ROIC2.58% 52W Low17.93 59.34% Perf 3Y18.20%
Dividend Est.0.84 (2.92%) EV/EBITDA8.36 Sales past 3/5Y0.15% 1.35% Gross Margin24.46% Volatility1.27% 1.35% Perf 5Y-34.35%
Dividend TTM0.81 (2.85%) EV/Sales1.36 EPS Y/Y TTM27.17% Oper. Margin8.02% ATR (14)0.54 Perf 10Y-33.73%
Dividend Ex-DateMay 23, 2025 Quick Ratio1.08 Sales Y/Y TTM-0.91% Profit Margin3.18% RSI (14)56.97 Recom2.76
Dividend Gr. 3/5Y17.26% 9.58% Current Ratio1.46 EPS Q/Q106.71% SMA201.57% Beta0.85 Target Price29.37
Payout79.39% Debt/Eq0.75 Sales Q/Q0.19% SMA504.01% Rel Volume0.78 Prev Close28.21
Employees113840 LT Debt/Eq0.66 EarningsMay 06 BMO SMA20019.71% Avg Volume477.13K Price28.57
IPOSep 17, 1996 Option/ShortYes / Yes EPS/Sales Surpr.11.88% 4.47% Trades Volume371,310 Change1.28%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Mar-07-23Initiated Bernstein Mkt Perform
Jan-03-23Downgrade Jefferies Buy → Underperform $14 → $11.70
Today 02:29PM
Jun-25-25 09:40AM
Jun-24-25 08:19AM
Jun-18-25 11:40AM
Jun-17-25 11:33AM
08:56AM Loading…
08:56AM
07:00AM
Jun-09-25 09:40AM
Jun-04-25 12:31PM
12:00PM
08:00AM
Jun-02-25 09:50AM
May-30-25 08:00AM
May-27-25 08:24AM
May-22-25 11:45AM
09:40AM Loading…
09:40AM
May-15-25 12:00PM
09:50AM
08:06AM
May-09-25 07:08AM
05:44AM
04:36AM
May-08-25 03:08AM
03:08AM
May-07-25 08:09PM
12:30PM
May-06-25 10:25AM
09:40AM
07:00AM
May-05-25 11:09AM
11:05AM Loading…
May-02-25 11:05AM
08:30AM
May-01-25 11:46AM
11:34AM
11:32AM
10:40AM
09:13AM
Apr-30-25 11:25AM
Apr-29-25 01:10PM
Apr-28-25 01:18PM
11:24AM
Apr-27-25 05:08AM
Apr-25-25 12:50PM
12:48PM
Apr-24-25 01:02PM
11:36AM
Apr-23-25 12:39PM
09:40AM
Apr-21-25 09:57AM
Apr-17-25 09:40AM
08:50AM
Apr-16-25 09:07AM
06:30AM
Apr-15-25 09:45AM
Apr-14-25 09:40AM
Apr-11-25 09:50AM
Apr-10-25 01:19PM
09:03AM
Apr-09-25 08:57AM
Apr-07-25 09:40AM
Apr-04-25 12:37PM
11:02AM
09:40AM
08:27AM
Apr-03-25 11:30AM
Apr-02-25 03:34PM
08:35AM
Apr-01-25 10:41AM
10:02AM
09:42AM
09:40AM
Mar-31-25 08:47AM
Mar-28-25 11:30AM
10:25AM
Mar-27-25 05:00AM
05:00AM
Mar-26-25 11:59AM
11:44AM
07:47AM
Mar-25-25 10:39AM
Mar-24-25 11:50AM
10:15AM
10:15AM
07:41AM
Mar-20-25 09:40AM
09:38AM
05:00AM
Mar-19-25 10:15AM
Mar-13-25 08:00AM
Mar-04-25 02:50AM
Feb-25-25 10:15AM
07:00AM
Feb-24-25 08:00AM
Jan-07-25 07:57AM
Dec-23-24 09:00AM
Dec-20-24 11:23AM
Nov-19-24 09:00AM
Nov-06-24 06:33AM
Nov-05-24 10:19AM
07:00AM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.